Physician profile
Steven G Pascal
NPI 1336177245
$5,220.12
in general payments reported to CMS, 2019-2025
29 companies · $1,059 in 2025
The $1,059 reported for 2025 was more than what 78% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $328 · 2020: $349 · 2021: $342 · 2022: $588 · 2023: $1,149 · 2024: $1,404 · 2025: $1,059.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,612.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,612.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $890.22 | 2022-2025 | |
| Alcon Vision LLC | $856.02 | 2020-2025 | Clareon, Rocklatan, Hydrus Microstent |
| Oyster Point Pharma, INC. | $407.57 | 2022-2025 | Tyrvaya, Ryzumvi, Tyrvaya |
| Sun Pharmaceutical Industries INC. | $339.32 | 2019-2025 | Cequa |
| Novartis Pharmaceuticals Corporation | $326.21 | 2019-2023 | |
| Sight Sciences, INC. | $277.21 | 2019-2025 | Omni Surgical System, Sion Surgical Instrument |
| Glaukos Corporation | $274.59 | 2022-2025 | Istent Infinite, Idosetr, Istent Trabecular Micro-Bypass System Model Is3 |
| Bausch & Lomb Americas INC. | $245.15 | 2022-2025 | Xiidra, Miebo, Envista Mx60 Iol |
| Allergan, INC. | $220.15 | 2019-2021 | |
| New World Medical,INC. | $180.69 | 2023-2024 | Streamline, Kahook Dual Blade, Ahmed Glaucoma Valve |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $144.69 | 2019-2020 | |
| Harrow Eye, LLC | $136.27 | 2024-2025 | Vevye |
| Tarsus Pharmaceuticals, INC. | $132.30 | 2024-2025 | Xdemvy |
| Biotissue Holdings INC. | $112.03 | 2025 | |
| Mallinckrodt Hospital Products INC. | $87.79 | 2022-2024 | Acthar |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $78.55 | 2024-2025 | Iyuzeh |
| Carl Zeiss Meditec USA, INC. | $65.53 | 2023 | Cirrus Hd-Oct |
| Optos, INC. | $52.47 | 2019 | |
| Omeros Corporation | $49.41 | 2019 | |
| Aerie Pharmaceuticals, INC. | $46.67 | 2020-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $46.37 | 2023-2024 | Tecnis Iol, Tecnis Simplicity, Tecnis Iol |
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Rxsight INC | $38.43 | 2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Ivantis, INC | $36.09 | 2020 | |
| Apellis Pharmaceuticals, INC. | $34.91 | 2025 | Syfovre |
| Amgen INC. | $33.60 | 2024 | Tepezza |
| Akorn, INC. | $23.61 | 2020 | |
| Kala Pharmaceuticals, INC. | $23.34 | 2021 | |
| Dompe US, INC. | $22.13 | 2025 | Oxervate |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Pascal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.